Skip to main content
. 2020 Feb 18;21:200. doi: 10.1186/s13063-020-4120-y

Table 1.

Distribution by country of nepafenac trial participants

Country Number of subjects % of total subjects
United States 500 83.6
Panama 26 4.3
Puerto Rico 54 9
Other 18 3
Total 598 100